Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Aspirin inhibits osteoclastogenesis by suppressing the activation of NF-κB and MAPKs in RANKL-induced RAW264.7 cells.

Zeng YP, Yang C, Li Y, Fan Y, Yang HJ, Liu B, Sang HX.

Mol Med Rep. 2016 Sep;14(3):1957-62. doi: 10.3892/mmr.2016.5456. Epub 2016 Jun 30.

2.

Recombinant Human Endostatin Suppresses Mouse Osteoclast Formation by Inhibiting the NF-κB and MAPKs Signaling Pathways.

Chen N, Gao RF, Yuan FL, Zhao MD.

Front Pharmacol. 2016 Jun 1;7:145. doi: 10.3389/fphar.2016.00145. eCollection 2016.

3.

Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model.

Qiao H, Wang TY, Yu ZF, Han XG, Liu XQ, Wang YG, Fan QM, Qin A, Tang TT.

Cell Death Dis. 2016 Feb 11;7:e2094. doi: 10.1038/cddis.2016.11.

4.

Signaling Pathways in Osteoclast Differentiation.

Kim JH, Kim N.

Chonnam Med J. 2016 Jan;52(1):12-7. doi: 10.4068/cmj.2016.52.1.12. Epub 2016 Jan 19. Review.

5.

ADP-Ribosylation Factor 1 Regulates Proliferation, Migration, and Fusion in Early Stage of Osteoclast Differentiation.

Kim MJ, Kim H, Lee SH, Gu DR, Lee SY, Lee K, Jeong D.

Int J Mol Sci. 2015 Dec 9;16(12):29305-14. doi: 10.3390/ijms161226168.

6.

Andrographolide Inhibits Ovariectomy-Induced Bone Loss via the Suppression of RANKL Signaling Pathways.

Wang T, Liu Q, Zhou L, Yuan JB, Lin X, Zeng R, Liang X, Zhao J, Xu J.

Int J Mol Sci. 2015 Nov 17;16(11):27470-81. doi: 10.3390/ijms161126039.

7.

Photoprotective Potential of Penta-O-Galloyl-β-DGlucose by Targeting NF-κB and MAPK Signaling in UVB Radiation-Induced Human Dermal Fibroblasts and Mouse Skin.

Kim BH, Choi MS, Lee HG, Lee SH, Noh KH, Kwon S, Jeong AJ, Lee H, Yi EH, Park JY, Lee J, Joo EY, Ye SK.

Mol Cells. 2015 Nov;38(11):982-90. doi: 10.14348/molcells.2015.0169. Epub 2015 Nov 4.

8.

Effects of Human Mesenchymal Stem Cells Transduced with Superoxide Dismutase on Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice.

Sah SK, Park KH, Yun CO, Kang KS, Kim TY.

Antioxid Redox Signal. 2016 Feb 10;24(5):233-48. doi: 10.1089/ars.2015.6368. Epub 2015 Nov 18.

PMID:
26462411
9.

Lycorine suppresses RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced osteoporosis and titanium particle-induced osteolysis in vivo.

Chen S, Jin G, Huang KM, Ma JJ, Wang Q, Ma Y, Tang XZ, Zhou ZJ, Hu ZJ, Wang JY, Qin A, Fan SW.

Sci Rep. 2015 Aug 4;5:12853. doi: 10.1038/srep12853.

10.

Focus on the p38 MAPK signaling pathway in bone development and maintenance.

Thouverey C, Caverzasio J.

Bonekey Rep. 2015 Jun 10;4:711. doi: 10.1038/bonekey.2015.80. eCollection 2015. Review.

11.

The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors.

Lin J, Lee D, Choi Y, Lee SY.

Sci Signal. 2015 Jun 2;8(379):ra54. doi: 10.1126/scisignal.2005867.

12.

Sexual Dimorphism in MAPK-Activated Protein Kinase-2 (MK2) Regulation of RANKL-Induced Osteoclastogenesis in Osteoclast Progenitor Subpopulations.

Herbert BA, Valerio MS, Gaestel M, Kirkwood KL.

PLoS One. 2015 May 6;10(5):e0125387. doi: 10.1371/journal.pone.0125387. eCollection 2015.

13.

Biphasic silica/apatite co-mineralized collagen scaffolds stimulate osteogenesis and inhibit RANKL-mediated osteoclastogenesis.

Jiao K, Niu LN, Li QH, Chen FM, Zhao W, Li JJ, Chen JH, Cutler CW, Pashley DH, Tay FR.

Acta Biomater. 2015 Jun;19:23-32. doi: 10.1016/j.actbio.2015.03.012. Epub 2015 Mar 16.

14.

Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis.

Gu R, Santos LL, Ngo D, Fan H, Singh PP, Fingerle-Rowson G, Bucala R, Xu J, Quinn JM, Morand EF.

Cytokine. 2015 Apr;72(2):135-45. doi: 10.1016/j.cyto.2014.11.015. Epub 2015 Jan 31.

15.

Dual Effect of Chrysanthemum indicum Extract to Stimulate Osteoblast Differentiation and Inhibit Osteoclast Formation and Resorption In Vitro.

Baek JM, Kim JY, Cheon YH, Park SH, Ahn SJ, Yoon KH, Oh J, Lee MS.

Evid Based Complement Alternat Med. 2014;2014:176049. doi: 10.1155/2014/176049. Epub 2014 Oct 28.

16.

Angelica sinensis extract inhibits RANKL-mediated osteoclastogenesis by down-regulated the expression of NFATc1 in mouse bone marrow cells.

Kong L, Zhao Q, Wang X, Zhu J, Hao D, Yang C.

BMC Complement Altern Med. 2014 Dec 12;14:481. doi: 10.1186/1472-6882-14-481.

17.

Choline kinase β mutant mice exhibit reduced phosphocholine, elevated osteoclast activity, and low bone mass.

Kular J, Tickner JC, Pavlos NJ, Viola HM, Abel T, Lim BS, Yang X, Chen H, Cook R, Hool LC, Zheng MH, Xu J.

J Biol Chem. 2015 Jan 16;290(3):1729-42. doi: 10.1074/jbc.M114.567966. Epub 2014 Dec 1.

18.

Fucoidan, a sulfated polysaccharide, inhibits osteoclast differentiation and function by modulating RANKL signaling.

Kim YW, Baek SH, Lee SH, Kim TH, Kim SY.

Int J Mol Sci. 2014 Oct 20;15(10):18840-55. doi: 10.3390/ijms151018840.

19.

The study of mechanisms of protective effect of Rg1 against arthritis by inhibiting osteoclast differentiation and maturation in CIA mice.

Gu Y, Fan W, Yin G.

Mediators Inflamm. 2014;2014:305071. doi: 10.1155/2014/305071. Epub 2014 Aug 21.

20.

TRP14 inhibits osteoclast differentiation via its catalytic activity.

Hong S, Huh JE, Lee SY, Shim JK, Rhee SG, Jeong W.

Mol Cell Biol. 2014 Sep 15;34(18):3515-24. doi: 10.1128/MCB.00293-14. Epub 2014 Jul 7.

Items per page

Supplemental Content

Write to the Help Desk